Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Richter, J. R.; Wermke, M.; Kauh, J. S.; Back, J.; Salhi, Y.; Reddy, V.; Bayever, E.; Landgren, C. O. |
| Abstract Title: | Phase 1, multicenter, open-label study of single-agent bispecific antibody T-cell engager GBR 1342 in relapsed/refractory multiple myeloma |
| Meeting Title: | 2018 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2018 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-02-10 |
| Language: | English |
| ACCESSION: | WOS:000436177700079 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2018.36.5_suppl.TPS81 |
| Notes: | Meeting Abstract: TPS81 -- Source: Wos |
